Fresenius Medical Care AG & Co. KGaA (FMS) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Care Facilities secteur d'activité. Le siège social de l'entreprise est situé à Bad Homburg, Germany. Le PDG actuel est Helen Giza.
FMS a date d'introduction en bourse 1996-09-17, 112,035 employés à temps plein, cotée sur le NYSE, une capitalisation boursière de $13.38B.
Fresenius Medical Care AG & Co. KGaA is a global leader in dialysis care and renal disease treatment, operating approximately 4,171 outpatient dialysis clinics across 150 countries. The company provides comprehensive dialysis services including treatment delivery, laboratory diagnostics, patient support, and clinical monitoring, alongside specialized services for hospitalized end-stage renal disease patients and those with acute kidney failure. It manufactures and distributes a broad portfolio of dialysis products such as dialyzers, hemodialysis machines, peritoneal dialysis solutions, and water treatment systems, as well as renal pharmaceuticals and non-dialysis products including cardiopulmonary and apheresis solutions. Additionally, the company offers vascular care, cardiovascular services, and physician nephrology and cardiology services through ambulatory surgery centers. Headquartered in Bad Homburg, Germany, Fresenius Medical Care distributes its products through direct sales channels, independent distributors, and dealers to dialysis clinics, hospitals, and specialized treatment facilities worldwide.
